SCHEMBL16375207

SCHEMBL16375207

O=C(NC(Cc1ccc(-c2ncc(-c3ccccc3)cn2)cc1)C(=O)N1CCCC(C(=O)O)C1)c1cccs1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 1/20 0.43
▸ F10 P00742 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.42
▸ HSP90AA1 P07900 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ HSPA1A P0DMV8 1/20 0.42
▸ HSPA5 P11021 1/20 0.42
▸ HSPA9 P38646 1/20 0.42
▸ HSPA2 P54652 1/20 0.42
▸ FPR2 P25090 1/20 0.41
▸ MMP2 P08253 2/20 0.41
▸ MMP8 P22894 2/20 0.41
▸ MMP12 P39900 2/20 0.41
▸ PLG P00747 2/20 0.41
▸ PLAU P00749 2/20 0.41
▸ PRCP P42785 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CTSL P07711 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16375205 0.95 HSPA1A (0.43) F10ALDH1A1HSPA1AHSPA5HSPA9
SCHEMBL17994246 0.93 RAB9A (0.43) RAB9AF10ALDH1A1HSP90AA1MAPT
SCHEMBL16375214 0.92 HSPA5 (0.46) HSPA1AHSPA5HSPA9HSPA2CYP3A4
SCHEMBL16375211 0.90 KMT2A (0.46) F10FPR2MEN1KMT2A
SCHEMBL17994245 0.88 HSPA1A (0.41) ALDH1A1HSPA1AHSPA5HSPA9HSPA2
SCHEMBL16375210 0.85 TSHR (0.51) —
SCHEMBL16375209 0.84 KMT2A (0.47) CYP3A4KMT2A
SCHEMBL17994253 0.84 HSPA5 (0.43) RAB9AMAPTHSPA1AHSPA5HSPA9
SCHEMBL17994252 0.83 FPR2 (0.47) F10FPR2MEN1KMT2A
SCHEMBL16306082 0.81 PRCP (0.42) F10FPR2PLGPLAUPRCP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170313717-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2017-11-02 — — US disclosed
US-9598430-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2017-03-21 — — US disclosed
US-20160214993-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2016-07-28 — — US disclosed
US-20150011527-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2015-01-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170313717-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R RAB9A 609/4885F10 1321/4885ALDH1A1 4770/4885
US-20160214993-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R RAB9A 609/4885F10 1321/4885ALDH1A1 4770/4885
US-20150011527-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R RAB9A 609/4885F10 1321/4885ALDH1A1 4770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback